standard dose of TPA for 15 weeks, after various delays. However, our data suggest that the decrease in tumour yields is chiefly or wholly due to a reduction, among ageing mice, of the ability to respond to promoters, and not to any substantial loss of initiated cells, for late initiation with immediate promotion also yielded a less rapid response than early initiation with immediate promotion. Interpretation of all such studies is complicated by the few weeks that the skin needs to repair ulceration and other damage induced by the higher doses of DMBA, for if promotion with TPA begins before such repair is complete the tumour yield may be misleadingly increased.
Time between initiation and promotion.-When mouse skin is "initiated" with a single dose of DMBA (7,12-dimethyl benz(a)anthracene) and is then "promoted" with regular treatment for several weeks or months with croton oil or an active extract of it (Hecker, 1971) such as the phorbol ester TPA (12-0-tetradecanoyl-phorbol-1 3-acetate), it is well known that "papillomas" will arise. However, there are conflicting claims (see below) in the literature as to whether the quantitative response to this combination of treatments is the same if mice initiated at age 6-10 weeks are kept after initiation for several months before promotion begins.
Dose of initiator per unit area.-If the local concentration of initiator on mouse skin is large enough to cause ulceration or skin erosion or inflammation, then this complicates the experimental outcome since (i) skin healing after either mild or severe ulceration has sufficient promoting action § to cause some papillomas to arise without any external promotion, and
(ii) ulceration severe enough to remove the basal layer completely will remove some of the initiated cells that are to be studied, and it is unclear what proportion of initiated basal cells can be expected in the subsequent epithelial regrowth over a severely ulcerated area.
The likelihood of ulceration depends, of course, not only on the strain of mouse and the dose of initiator, but also on the volume and physical nature of the vehicle in which the initiator is applied. Some experiments have used 0-2 ml of acetone, which spreads the initiator over the whole shaved back of the mouse and reduces the likelihood of ulceration, while others have used only about 0 02 ml of liquid paraffin, which confines the initiator to an area less than 0-5 cm2 between the shoulder blades of the mouse. This has the advantage of preventing the animal from scratching the treated area, but at the expense of increasing the likelihood of ulceration.
Previous experiments. -Berenblum & Shubik (1949) studied female Swiss mice, the shaved backs of which were initiated with "a drop on the end of a fine glass rod" of a 1 5 % solution of DMBA in liquid paraffin. If the volume deposited was about 0 02 ml, each mouse must have received about 300 [kg of DMBA in a small region of the back. These mice were later promoted for 17 weeks with regular croton oil. In one experiment, 100 mice underwent promotion "early" (Weeks 3-20 after initiation), while in another experiment 25 mice underwent promotion "late"
(Weeks 43-60 after initiation). In both the "early" and the "late" experimenits, there was almost no intercurrent mortality, and about half the mice developed at least one papilloma, while half developed no papillomas. This apparent similarity of response of the animals promoted during Weeks 3-20 and 43-60 after initiation has generally been taken as evidence that initiation is essentially irreversible, a conclusion which has acted as an important stimulus to the fruitful development of ''multistage models" for cancer induction (e.g. Armitage & Doll, 1961 ; for review, see Peto, 1977 , or XVhittemore & Keller, 1978 .
Unfortunately, subsequent work has not confirmed the evidence* on which this conclusion rests, and delay between initiation and promotion does appear to decrease the response to the promoter (Roe & Salaman, 1954; Roe et al., 1972;  van Duuren et al., 1963 Duuren et al., , 1967 Duuren et al., , 1975 Duuren et al., , 1978 Hieger, 1965 (Berenblum & Sliubik, 1947a,b) these same treatments catused many ear-ly (leatlis and produced papillomas amonig almost all tlhat, (lid not die. Moreover, Roe et al. (1972) obtained an average of 8 ttumours per Swiss moluse by applying only 100 ,ug of DMBA (albeit in 0-2 ml acetone) before promotion. Lacking any obx-ious explanatioin, the possibility of teclnical error by Berenblum & Sliuibik (1949) efficacy of the initiator (Berenblum et al., 1958 ; see also Manil et al., 1981) . To determine wArhether animals Aere in resting stage, their entire backs were shaved, and 1 week later thev were examined for signs of regrowth. At Week 8, animals then in the resting stage were randomized 5 ways, between delayed initiation and immediate initiation wNith a particular one of the 4 DMBA doses, while all animals not in the resting stage were put into the "delayed initiation" group. (Because of the presumed uniformity of the hair cycle in all animals, it was not felt that the "delayed" group wA-ould thereby be biased, but w-e have no direct check on this supposition.) At Week 48 the survivors of the "delayed" group which wN-ere then in the resting stage Awere likewise randomized 5 wAays, one group plus those not in the resting stage at Week 48 having their DMBA initiation further delayed.
At Week 68 all animals were randomized irrespective of hair cycle, but the treatment of those undergoing regrowth was delayed for a week to allow reversion to the resting stage.
Tumours and other skin lesions-.Animals were checked weekly and gross appearance, behaviour, nutritional status, etc., were recorded. All skin lesions were measured and charted wNeekly, size and gross appearance (apparent nature, shape, colour, necrosis, etc.) being noted. For each tumour we recorded, where relevant, any preceding lesions (e.g. ulceration or hyperplasia), week of appearance, wNeek of apparent progression from one type of tumour to another, and wieek of regression. Particular care was taken to record accurately the week w,hen a tumour first attained a maximal diameter of at least 10 mm.
Histology.-A complete necropsy was performed and all grossly visible lesions, diseases, tumours, etc. were recorded. All skin lesions and tumours, plus selected specimens from other organs, were studied histologically. Formalin-fixed, paraffin-embedded specimens were sectioned, stained with haematoxylin and eosin and other stains as needed, and examined histologically by F. Stenback, using standard criteria for morphology (Stenback, 1969 (iii) , and (iv) of titne to the first ocurrence of some specified type of tumour, differences in longevity must be allowed for -when calculating expected numbers (IARC, 1980) . Advantages of using Os and Es include the facts that:
(a) Different comparisons can be pooled simply by adding up the corresponding Os and Es: many examples will be found in the appendices to these 3 papers.
(b) P values for the differences between groups in respect of numbers of tumourbearing animals (although not for the total numbers of tumours) can be derived from the differences between Os and Es (as in Peto & Pike, 1973; for discussion, see IARC, 1980) .
(c) The ratios O/E provide a useful description of the relative impact of the tumour type of interest on the particular groups being compared and, when the O/E values for the 4 different indices of response (i-iv) all give a similar impression, a satisfactory characterization of the differences between those groups has been achieved.
A fuller discussion of the statistical methods (ii), (iii), and (iv) that we have used for our analyses of time-to-tumour may be found in the annex on statistical methodology for animal experiments to IARC (1980) , the methods used being those described for tumours that are observed in a "mortalityindependent" context.
Appendix Table ( a) summarizes certain indices of response to promotion in the 8 groups -which wN,ere scheduled to be promoted. (Because promotion lasted for 15 weeks only, the papillomatous response to promotion is adequately characterized by the tumour yield within 20 weeks of starting promotion.)
RESULTS
This first paper now deals only with the persistence of initiation, which was the main question we wished to study. Our second paper (Stenback et al., 1981a) deals with systematic differences between the effects of giving the same initiating dose at different ages, followed by the same interval before promotion. Our third paper (Stenback et al., 1981b) Tables b and c ). In Fig. 2 it is apparent that the tumour yields are not constant (P=0 0004 for trend), as was also found by Roe et al. (1972) larger study.* Despite this reservation, the most economical explanation for the observed similarity between these 2 patterns is that the one factor which is common to Fig. 2 and ibid., Fig. 1 i.e. promotion at 71-86 weeks rather than earlier, explains the decrease in effect in both graphs. If it is provisionally accepted that promotion at about 18 months of age is about 50%0 less potent than pronmotion during the first year or so of adult life, our data offer no evidence whatever for any substantial loss of initiated cells as initiated mice grow older. Fig. 3 . Another contribution to it would be provided by our previous postulate that, if TPA is given promptly (3 weeks) after DMBA, the net promotional effect is greater (owing, perhaps, to aggravation of the promotional effects of wound healing, or perhaps to interference with slow DNA repair). Between them, the hypotheses invoked previously are supported by, and account naturally for, the statistically significant difference seen in Fig. 3 .
Thus far we have supposed that the numbers of initiated cells produced by a given dose of DMBA does not vary much with age, and that there is no material loss of initiated cells as animals age. We have then inferred that the promotional * Tlbe approximate stu(ly sizes to date in wlmieb the effects of (lelaying promotbon liav-e beeni studied are 120 (1949) , 50 (1954), 30 (1963), 60() (1965), 80 (1967), 310 (1972) , 560 (1975/8) andl now 2200 mice (1980 Fig. 4 does not.* Among our many comparisons, this is the only result which is not concordant with our hypotheses. Moreover, since the predicted increase in tumour yield when initiation jtust precedes promotion is clearly seen in Fig. 5 , the lack of it in Fig. 4 Duuren et al. (1978) and the present study show conclusively that Berenblum & Shubik's quantitative findings were not reproducible, but the present study suggests that their conclusion was substantially correct, at least to within a factor of 2.
Initiation is probably more or less irreversible, and the effects of initiation with subtumorigenic doses of DMBA are probably more or less independent of age. However, (i) the efficacy of promoters appears to decrease in ageing mice, (ii) if DMBA doses large enough to kill skin cells are given the promotional effects of the resultant healing processes are greater in older than in younger mice, and (iii) if promotion is administered before the skin has been given a chance to settle down again after initiation, the tumour yield will be greater.
These conclusions explain naturally why it was that, when Peto et al. (1975) tested on mouse skin the carcinogenicity of repeated subtoxic doses of benzo(a) pyrene (a chemical which resembles DMBA much more than TPA in its likely mode of action) they found, after correcting by life-table methods for intercurrent mortality, that the neoplastic response was independent of the age (10, 25, 40, or 55 weeks) at which treatment began. It appears to be the promotional, rather than the initiating, processes which vary with age, and which account for most or all of the anomalies which we and others have observed.
Whether analogous promnotional processes govern human tumour induction is not known. It should be emphasized that although the little papillomas that can be elicited rapidly by TPA have been referred to as "tumours", both by us and by many others who have studied initiation and promotion on mouse skin, their biological nature is very different from that of an invasive carcinoma. In particular, many of them are not autonomous and may either shrink or disappear completely when regular treatment with TPA ceases (or even, in some instances, while it continues). There is obviously no necessary analogy between the aetiologies of such lesions and of invasive carcinomas. But we note that, in our analyses where there were a sufficient number of carcinomas for statistical stability, the observed effects of the various delays of initiation and promotion on invasive carcinomas have generally been rather similar to the effects on papillomas. 
